<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03530969</url>
  </required_header>
  <id_info>
    <org_study_id>18-183</org_study_id>
    <nct_id>NCT03530969</nct_id>
  </id_info>
  <brief_title>Geriatric Communication Skills Training Program for Oncology Clinicians</brief_title>
  <official_title>Geriatric Communication Skills Training Program for Oncology Clinicians to Improve Management of Care for Geriatrics Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Memorial Sloan Kettering Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Memorial Sloan Kettering Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to learn more about the effects of a training program designed
      to help doctors communicate better with older patients and their caregivers.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 7, 2018</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility of Health Care Provider (HCP) training</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measured by number of HCP successfully recruited for the training</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Participants satisfaction with Health Care Provider (HCP) training</measure>
    <time_frame>1 week</time_frame>
    <description>Self-reported measure of satisfaction</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">88</enrollment>
  <condition>GI Cancer</condition>
  <condition>Lymphoma</condition>
  <condition>GU Cancer</condition>
  <condition>Bone Marrow Transplant</condition>
  <arm_group>
    <arm_group_label>GI/GU/Lymphoma Oncologists</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Doctors specializing in treating gastrointestinal cancer (cancer of the stomach, pancreas, colon, etc.), genitourinary cancer (cancer of the genitals and urinary tract), and lymphoma (cancer affecting the blood and lymph nodes)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Participants with GI/GU/Lymphoma Cancer</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients of the physicians in group 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Caregivers of Participants with GI/GU/Lymphoma Cancer</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Family members or caregivers of the patients in group 2</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Self-Efficacy Assessment</intervention_name>
    <description>Health Care Professional's self-efficacy will be assessed by 12 ratings of self-reported confidence from (1) &quot;strongly disagree&quot; to (5) &quot;strongly agree&quot; in module-specific topics both before and after the training.</description>
    <arm_group_label>GI/GU/Lymphoma Oncologists</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>UCLA Geriatrics Attitudes Scale</intervention_name>
    <description>The UCLA Geriatrics Attitudes Scale is a 14-item scale developed to assess health care providers' attitudes toward older persons and caring for older patients.</description>
    <arm_group_label>GI/GU/Lymphoma Oncologists</arm_group_label>
    <other_name>Perceived Ageism</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Course Evaluations</intervention_name>
    <description>The evaluation surveys for each of the three modules will contain fifteen statements assessing post-training attitudes regarding the skills learned and application of skills in oncology clinical practice, measured on a 5-point Likert scale.</description>
    <arm_group_label>GI/GU/Lymphoma Oncologists</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>The Consultation and Relational Empathy (CARE) questionnaire</intervention_name>
    <description>The Consultation and Relational Empathy (CARE) questionnaire is a 10-item self-report scale that measures a patient's satisfaction with how empathic their health care providers (HCP) was within a specific consultation.</description>
    <arm_group_label>Caregivers of Participants with GI/GU/Lymphoma Cancer</arm_group_label>
    <arm_group_label>Participants with GI/GU/Lymphoma Cancer</arm_group_label>
    <other_name>Perceived Empathy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Consumer Assessment of Health Care Providers and Systems Program (CAHPS)</intervention_name>
    <description>Patientsâ€Ÿ perceptions of the quality of their interactions with their clinicians will be rated with 6 items from the Consumer Assessment of Health Care Providers and Systems Program (CAHPS)</description>
    <arm_group_label>Caregivers of Participants with GI/GU/Lymphoma Cancer</arm_group_label>
    <arm_group_label>Participants with GI/GU/Lymphoma Cancer</arm_group_label>
    <other_name>Satisfaction with communication</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Patient activation measure (PAM) scale</intervention_name>
    <description>The PAM scale contains 22 items that assess patient engagement in their care process.</description>
    <arm_group_label>Participants with GI/GU/Lymphoma Cancer</arm_group_label>
    <other_name>Patient Activation.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Clinician Eligibility

          -  MSK medical oncology Health Care Professionals (HCP) - specifically identified as
             Attendings, fellows, or Advance Practice Professional (APP) - either a Nurse
             Practitioner (NP) or Physician Assistant (PA) from GI, GU Oncology, Lymphoma, Bone
             Marrow Transplant or Geriatrics Service (five services with a large number of
             geriatric patients)

          -  Willingness to be audio-recorded as per self-report

          -  Clinician has individual clinic consultations with patients in the target population:
             65 years of age and over, English speaking, and patients who have had a new visit
             within the last 6 months.

        Patient Eligibility

          -  MSK patients 65 years of age and over as per EMR

          -  English speaking as per EMR

          -  Being seen by one of the consented HCPs as per the HCP and/or electronic medical
             record (EMR)

          -  Willingness to be audio-recorded as per self-report

          -  Patient had their first visit with the clinician within the last 6 months

        Caregiver Eligibility

          -  English speaking as per EMR

          -  Accompanying an MSK patient being seen by one of the consented HCPs as per the HCP
             and/or EMR

        Exclusion Criteria:

          -  N/A
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Smita Banerjee, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Memorial Sloan Kettering Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mskcc.org</url>
    <description>Memorial Sloan Kettering Cancer Center</description>
  </link>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>May 8, 2018</study_first_submitted>
  <study_first_submitted_qc>May 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2018</study_first_posted>
  <last_update_submitted>March 16, 2020</last_update_submitted>
  <last_update_submitted_qc>March 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

